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Humans on Cardiac Magnetic Resonance
Quantitative Assessment During Follow-Up and Validation With
Single-Photon Emission Computed Tomography
Marcus Carlsson, MD, PHD,* Joey F. A. Ubachs, MD,* Erik Hedström, MD, PHD,*
Einar Heiberg, PHD,* Stefan Jovinge, MD, PHD,† Håkan Arheden, MD, PHD*
Lund, Sweden
O B J E C T I V E S Our goal was to validate myocardium at risk on T2-weighted short tau inversion
recovery (T2-STIR) cardiac magnetic resonance (CMR) over time, compared with that seen with perfusion
single-photon emission computed tomography (SPECT) in patients with ST-segment elevation myocar-
dial infarction, and to assess the amount of salvaged myocardium after 1 week.
B A C KG ROUND To assess reperfusion therapy, it is necessary to determine howmuch myocardium
is salvaged by measuring the ﬁnal infarct size in relation to the initial myocardium at risk of the left
ventricle (LV).
METHOD S Sixteen patients with ﬁrst-time ST-segment elevation myocardial infarction received
99mTc tetrofosmin before primary percutaneous coronary intervention. SPECT was performed within 4 h
and T2-STIR CMR within 1 day, 1 week, 6 weeks, and 6 months. At 1 week, patients were injected with
a gadolinium-based contrast agent for quantiﬁcation of infarct size.
R E S U L T S Myocardium at risk at occlusion on SPECT was 33 10% of the LV. Myocardium at risk on
T2-STIR did not differ from SPECT, at day 1 (29  7%, p  0.49) or week 1 (31  6%, p  0.16) but
declined at week 6 (10  12%, p  0.0096 vs. 1 week) and month 6 (4  11%, p  0.0013 vs. 1 week).
There was a correlation between myocardium at risk demonstrated by T2-STIR at week 1 and
myocardium at risk by SPECT (r2  0.70, p  0.001), and the difference between the methods on
Bland-Altman analysis was not signiﬁcant (2.3  5.7%, p  0.16). Both modalities identiﬁed
myocardium at risk in the same perfusion territory and in concordance with angiography. Final infarct
size was 8  7%, and salvage was 75  19% of myocardium at risk.
CONC L U S I O N S This study demonstrates that T2-STIR performed up to 1 week after reperfusion
can accurately determine myocardium at risk as it was before opening of the occluded artery. CMR can
also quantify salvaged myocardium as myocardium at risk minus ﬁnal infarct size. (J Am Coll Cardiol
Img 2009;2:569–76) © 2009 by the American College of Cardiology Foundation
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570yocardial infarction (MI) size depends
heavily on duration of occlusion, collat-
eral flow, and size of the initial myo-
cardium at risk (1–3). Therefore, ST-
egment elevation myocardial infarction (STEMI)
s treated with reperfusion therapy as soon as
ossible. The myocardium at risk, defined as the
ypoperfused myocardium during acute coronary
cclusion, is an important measure, since a vari-
ble amount of this area will become infarcted
4). Therefore, to assess the efficacy of reperfu-
ion therapy, it is necessary to determine how
uch myocardium is salvaged by measuring the
nal infarct size in relation to the initial myocar-
ium at risk.
See page 577
MI size has earlier been quantified by
single-photon emission computed tomog-
raphy (SPECT) after injection of a
technetium-labeled perfusion tracer at rest
(5), where MI is indirectly detected as a
region with decreased myocardial perfu-
sion. More recently, contrast delayed en-
hancement (DE) cardiac magnetic reso-
nance (CMR) has emerged as the new
reference method for infarct localization
and quantification (6–8).
Myocardium at risk can be measured on
SPECT by injection of a technetium-
based tracer before opening of the oc-
cluded vessel and is currently the most
widely practiced technique to determine
myocardium at risk (9–11). However,
rawbacks in the use of SPECT to estimate myo-
ardium at risk are the availability of a technetium-
ased tracer, the need for injection of the isotope in
he acute setting of coronary occlusion, and scan-
ing with a gamma camera after completion of
rimary percutaneous coronary intervention (PCI),
hich could interfere with patient care in the acute
etting. These factors have limited the applicability
f SPECT in measurement of myocardium at risk.
herefore, new clinical methods to quantify myo-
ardium at risk need to be developed.
T2-weighted short tau inversion recovery (T2-
TIR) highlights myocardial edema (12) present
fter MI (13) without the need of tracer adminis-
ration. Moreover, CMR with T2-STIR allows the
etection of the ischemic zone several days after the
ccluded coronary artery is opened (14,15). There-
r
y
ssion
ion
tore, CMR with T2-STIR can potentially be used sor quantification of myocardium at risk. Previous
tudies have shown the use of T2-STIR imaging for
cute infarction in both reperfused and nonreper-
used infarcts (12,14–17) and validated T2-STIR
or myocardium at risk in animals (14). There are,
owever, no validation studies in humans for the
uantification of myocardium at risk using T2-
TIR CMR. Hence, the purpose of this study was
o validate the measurement of the myocardium at
isk on T2-STIR over time, in comparison with
PECT in humans with acute MI, and to assess the
mount of salvaged myocardium after 1 week.
E T H O D S
tudy population and design. The study was ap-
roved by the local ethics committee, and all pa-
ients gave their written informed consent. Sixteen
atients (age 64  12 years, 14 men) with no
istory of MI, presenting with acute STEMI due to
n occluded coronary artery, were included in the
tudy. All patients were treated by primary PCI
ith coronary stents, resulting in Thrombolysis In
yocardial Infarction flow grade 3 in the opened
rtery and received glycoprotein IIb/IIIa inhibitor.
Before primary PCI, 99mTc tetrofosmin was ad-
inistered intravenously, and myocardial perfusion
PECT was performed 3 to 4 h after primary PCI
or determination of myocardium at risk. CMR
ith T2-STIR was undertaken 1 week after revas-
ularization. In 1 patient, adequate T2-STIR im-
ges at 1 week were not obtained. To determine the
ime evolution of the increase in T2-STIR signal,
arly imaging was performed at 1 day in 8 patients
nd within 2 days in 2 patients (hereafter described
s day 1), and 9 patients underwent CMR
ollow-up at 6 weeks and 6 months. For compari-
on, all patients underwent DE-CMR with admin-
stration of gadolinium at 1 week. The culprit vessel
as identified on angiography by 2 observers in
onsensus.
yocardial perfusion SPECT. Patients were injected
ith 500 to 700 MBq 99mTc tetrofosmin (Amer-
ham Health, Buckinghamshire, United Kingdom),
epending on body weight. Myocardial perfusion
lectrocardiogram-gated SPECT was performed
ccording to the standard clinical protocol at rest,
sing a dual-head camera. Nine patients were
maged using an ADAC Vertex camera (Milpitas,
alifornia), 7 patients with a cardiac dedicated GE
entri camera (GE Healthcare, Buckinghamshire,
nited Kingdom). The patients were placed in aB B R E V I A T I O N S
N D A C R O N YM S
MR cardiac magnetic
esonance
E delayed enhanced
V left ventricle/ventricula
Imyocardial infarction
CI percutaneous coronar
ntervention
PECT single-photon emi
omputed tomography
TEMI ST-segment elevat
yocardial infarction
2-STIR T2-weighted shorupine position and imaged in steps of 5.6° using a
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5714  64 matrix with a pixel size of 5.02 mm for the
DAC camera and a pixel size of 6.4 mm for the
E Ventri camera. Image acquisition time was
pproximately 15 min, but was extended to 25 min
hen imaging was performed after 3 h. Short- and
ong-axis images covering the left ventricle (LV)
ere reconstructed. Myocardium at risk was deter-
ined using an in-house developed segmentation
oftware (segment version 1.702) (18). The auto-
atic segmentation finds the centerline through the
V wall and identifies the endocardium and epicar-
ium based on an individually estimated wall thick-
ess and signal intensity values within the image.
anual adjustment of the automatic delineation
as sometimes required in the LV outflow region.
MR. CMR was performed on either of 2 1.5-T
ystems: Magnetom Vision (Siemens, Erlangen,
ermany) with a CP body array coil, or Philips
ntera CV (Philips, Best, the Netherlands) with a
ardiac synergy coil. All subjects were placed in a
upine position, and images were acquired at end-
xpiratory breath hold with electrocardiogram gat-
ng. Initial scout images were acquired to locate the
eart, and a T2-weighted double inversion blood
uppressed turbo spin echo sequence (T2-STIR)
as employed to depict myocardium at risk. T2-
TIR images were acquired in the short-axis view,
overing the LV from the base to apex. Image
arameters for T2-STIR were: echo time, 43 ms
Siemens), or 100 ms (Philips); repetition time, 2
eart beats; number of averages, 2; inversion time,
80 ms; image resolution, 1.5  1.5 mm; slice
hickness, 10 mm (Siemens), or 8 mm with a slice
ap of 2 mm (Philips). When acquiring images with
he cardiac synergy coil, parallel imaging with
ENSE  1 was used to minimize signal inhomo-
eneities due to differences in coil sensitivity.
Infarct quantification was performed on DE-
MR 30  9 min after intravenous administration
f 0.2 mmol/kg extracellular gadolinium-based
ontrast agent (gadoteric acid, Gd-DOTA; Guer-
et, Gothia Medical AB, Billdal, Sweden). DE-
MR with an inversion-recovery turbo fast low-
ngle shot sequence (Siemens) (slice thickness 10
m, field of view 380 mm, matrix 126  256, flip
ngle 25°, repetition time 100 ms, echo time 4.8
s) or an inversion-recovery balanced turbo field
cho sequence (Philips) (slice thickness 8 mm, field
f view 340 mm, repetition time 3.14 ms, echo time
.58 ms) was performed, covering the LV.
The CMR images were analyzed using the same
oftware as for the SPECT images (segment ver-
ion 1.702) (19). Observers were blinded to patient cata and time of acquisition after infarction. The
yocardium in each LV short-axis slice was man-
ally segmented by tracing the endocardial and
picardial borders. Regions of myocardium at risk
nd MI were identified as hyperenhanced regions,
ithin the T2-STIR images and DE-CMR im-
ges, respectively. The myocardium at risk region
as delineated manually by independent and
linded observers, and the infarcted region was
elineated automatically as previously described
ith manual adjustment when needed (19). Myo-
ardium at risk size and MI size were defined as the
otal amount of myocardium at risk/MI in all
hort-axis slices and expressed as percentage of LV
ass.
tatistical methods. Continuous variables are pre-
ented as mean  SD. Pearson’s correlation was
sed to determine the relationship between T2-
TIR and SPECT. Two-tailed paired t test was
sed to detect differences in myocardium at risk
etween techniques, differences in myocardium at
isk on T2-STIR at different time points, and the
nal infarct size compared with myocardium at risk
n T2-STIR. A p value 0.05 was considered
ignificant. Agreement between methods was ex-
ressed as mean difference  SD, and the limits of
greement were shown in a Bland-Altman graph as
ean difference  2 SD.
E S U L T S
yocardium at risk. Table 1 shows the patient char-
cteristics for all 16 patients included in this study.
igure 1 shows multislice images from base to apex
rom T2-STIR at week 1, SPECT at day 1, and
E-CMR at week 1 from 1 patient. Myocardium
t risk presented as a perfusion defect on SPECT
nd hyperenhanced regions on T2-STIR. In all
atients, T2-STIR and SPECT identified myocar-
ium at risk in the same perfusion territory and in
Table 1. Patient Characteristics
Male gender 14 (88%)
Age (yrs) 64 12 (36–83)
Body mass index (kg/m2) 27 3 (24–33)
Occluded artery by angiography
LAD 7 (44%)
RCA 8 (50%)
LCX 1 (6%)
Values are presented as n (%) or as mean  SD (range).
LAD  left anterior descending artery; LCX  left circumﬂex artery; RCA 
right coronary artery.oncordance with angiography. The resulting in-
f
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w
T
1

w
m
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572arction on DE-CMR was present in the same
egion in all patients.
Myocardium at risk on SPECT was 33 10% of
he LV and on T2-STIR at day 1 it was 29  7%
p 0.49 compared with SPECT). Myocardium at
isk on week 1 was 31  6% (p  0.16 compared
Figure 1. Myocardium at Risk by SPECT and T2-STIR CMR and F
Short-axis slices at the same ventricular level of single-photon emis
inversion recovery (T2-STIR) week 1, and delayed enhanced-cardiac
right coronary occlusion resulting in an inferior infarct. The epicard
affected region is traced in yellow. Note the similarity in size of the
sion by SPECT and T2-STIR CMR 1 week later, showing that T2-STIR
yocardium at Risk and Percentage Infarcted and Salvaged Myoc
T2-STIR
SPECT
(%)
Day 1
(%)
Week 1
(%)
Week 6
(%)
28 25 — 16
38 — 36 —
37 40 36 0
24 27 27 27
26 NA 24 13
38 30 36 0
28 — 23 —
39 25 26 30
34 34 34 0
39 39 31 —
20 18 25 5
20 27 25 —
46 — 42 —
31 — 29 0
25 — 30 —
56 — 43 —
3 10 29 7 31 6 10 12
p  0.49 p  0.16 p  0.00
rcent of myocardium salvaged in comparison with T2-STIR week 1; †salvaged mith SPECT) (Table 2). Myocardium at risk on
2-STIR at day 1 and week 1 did not differ (p 
.00). Over time, myocardium at risk declined to 10
12% at week 6 (p  0.0096 vs. T2-STIR at 1
eek and p  0.0026 vs. SPECT) and 4  11% at
onth 6 (p  0.0013 vs. T2-STIR at 1 week and
Infarct Size by DE-CMR in 1 Typical Patient
computed tomography (SPECT) day 1, T2-weighted short tau
netic resonance (DE-CMR) week 1 in a patient with reperfused
is traced in green, the endocardium is traced in red, and the
cted region between perfusion defect size during coronary occlu-
eek 1 can be used to quantify myocardium at risk.
ium
DE
Month 6
(%)
Week 1
(%)
Salvaged
Myocardium*
(%)
0 8 68.0†
— 16 55.6
0 2 94.4
0 16 40.7
5 7 70.8
0 19 47.2
— 1 95.7
32 10 61.5
— 2 94.1
0 0 100.0
— 2 92.0
— 1 96.0
— 19 54.8
0 6 79.3
0 10 66.7
— 7 83.7
4 11 8 7 75 19
p  0.001
rdium in comparison with T2-STIR day 1.inal
sion
mag
ium
affeTable 2. Percentage M ard
Patient #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Mean SD 3
vs. SPECT 26
*Salvaged myocardium: pe yoca
DE delayed enhanced; NA unable to appoint occluded vessel; SPECT single-photon emission computed tomography; T2-STIR T2-weighted short tau inversion recovery; – no imaging
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573 0.001 vs. SPECT). In patient 5, the observers
ere unable to designate the culprit vessel within
he T2-STIR images at day 1; however, at week 1
he myocardium at risk could be identified. Figure
A shows the relationship between myocardium at
isk demonstrated on T2-STIR at week 1 and
PECT (r2  0.70, p  0.001). There was no
tatistical significant difference between myocar-
ium at risk on T2-STIR compared with that of
PECT on Bland-Altman analysis (2.3  5.7,
 0.16) (Fig. 2B).
The evolution of myocardial edema in a patient
ith left anterior descending artery occlusion is
hown in Figure 3; SPECT is shown for compari-
on. The size of the affected region is similar at day
and week 1 on T2-STIR, but cannot be detected
t week 6 in this patient. Figure 4 displays the ratio
etween T2-STIR and SPECT at the different
cquisition times, day 1 (0.97 0.20), week 1 (0.97
0.18), week 6 (0.35  0.40), and month 6 (0.11
0.27).
yocardial salvage. The mean infarct size at week 1
as 8  7% LV (range 0% to 19%), significantly
maller than myocardium at risk (p  0.001)
Table 2). Myocardial salvage, calculated as the
ifference of T2-STIR and DE-CMR at week 1
as, on average, 75  19% (range 41% to 100%).
ne patient did not have any infarcted myocardium
n DE-CMR after the acute revascularization,
eaning that all myocardium was salvaged by
rimary PCI; salvage in this patient was therefore
00%. This patient underwent revascularization
ithin 1 h after pain onset. In patient 1, infarct size
y DE-CMR was compared with that of T2-STIR
t day 1 in absence of T2-STIR data at week 1. The
mount of salvaged myocardium is exemplified in 1
atient in Figure 5. Note that the salvage occurs in
he subepicardial layers of the myocardium.
Figure 3. T2-STIR Over Time in 1 Typical Patient
Midventricular short-axis slices of automatically delineated perfusion
delineation of T2-STIR over time, in the same patient with a left ant
endocardium is traced in red. The myocardium at risk is delineated
imaging is similar at day 1 and week 1, but disappears at week 6. AbbrSPECT (%LVM)
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Figure 2. Agreement Between T2-STIR and SPECT
(A) T2-STIR at week 1 versus perfusion defect during coronary occlusion by
SPECT (r2  0.70, p  0.001) with the line of identity. (B) Bland-Altman
graph showing the difference between myocardium at risk quantiﬁed on
T2-STIR (week 1) and SPECT versus the reference method SPECT. The differ-
ence between T2-STIR and SPECT was 2.3  5.7%. Solid lines  mean of
T2-STIR  SPECT; dotted lines  2 SD. LVM  left ventricular mass; otherdefect during coronary occlusion by SPECT and blinded manual
erior descending occlusion. The epicardium is traced in green; the
in yellow. Note that the signal of the affected region on T2-STIReviations as in Figure 1.
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574I S C U S S I O N
his study is the first to validate the quantification of
yocardium at risk on T2-STIR over time in com-
arison with that of SPECT, in patients with
TEMI. The main finding is that T2-STIR accu-
ately identifies and quantifies myocardium at risk up
o 1 week after opening of the occluded coronary
rtery. Thus, the success of reperfusion therapy can be
ssessed on CMR within 1 image session utilizing the
ombination of DE and T2-STIR to measure final
nfarct size and myocardium at risk, respectively, and
hereby measuring myocardial salvage.
yocardium at risk. Earlier studies (12,14–17,20)
ave demonstrated the use of T2-weighted imaging
or acute infarction, in both reperfused and non-
eperfused infarcts. The current study showed that
2-STIR accurately assessed myocardium at risk in
CMR day 1 CMR week 1 CMR week 6 CMR month 6
2-STIR Over Time in All Patients in Relation to Perfusion
cclusion by SPECT Imaging
een T2-STIR and SPECT at day 1, week 1, week 6, and month 6
0.20; 0.97  0.18; 0.35  0.40; and 0.11  0.27, respectively,
at the T2-STIR signal at day 1 and week 1 agree with perfusion
cclusion by SPECT imaging. The presence of edema at 6 months
in 2 of 9 patients. CMR  cardiac magnetic resonance; other
ns as in Figure 1.
Figure 5. Myocardial Salvage by CMR
Midventricular short-axis slices in a patient with a left circumﬂex
dium is traced in red. (Left) T2-STIR image showing the myocard
cardial infarction (delineated in yellow). (Right) T2-STIR image w
myocardium (blue area). Abbreviations as in Figure 1.eperfused infarcts in patients using SPECT at the
ime of coronary occlusion as the reference method.
n agreement with studies on humans (21,22) and
nimals (12,14,23), the area with high T2 signal
xceeded that of irreversible injury in acute MI.
athology studies in humans have shown complete
esorption of edema after acute MI within 5 weeks
13), and Aletras et al. (14) showed that edema was
till present at the 2-month follow-up CMR in a
anine model. No evidence of edema was found on
2-STIR in 7 of the 9 patients at 6 months after
he acute coronary occlusion in the present study.
ne may hypothesize that these 2 patients may
ave had residual or recurring ischemia within the
ame myocardial region.
Myocardial ischemia increases cellular and extra-
ellular osmolarity, alters plasma membrane perme-
bility, causes cell swelling and interstitial edema
24). Quantification of interstitial edema has been
emonstrated in experimental studies of myocar-
ium at risk after reperfusion by light microscopy,
utoradiography, and contrast-enhanced inversion
ecovery echo-planar CMR (25). Once reperfusion
s established, an inflammatory reaction within the
erfusion bed of the culprit vessel takes place, which
ignificantly increases tissue edema. Myocardial
dema is therefore a consistent feature of acute
schemia (26), which can be demonstrated on T2-
TIR (12) although the myocardium is reperfused
14,15). The results of the present study showed
hat the amount of edema present after 1 week was
imilar to the amount of edema at 1 day after
eperfusion.
Advantages of T2-STIR over SPECT in assess-
ng myocardium at risk are: 1) no need of tracer
dministration; 2) no complicated imaging interfer-
ng with patient care in the acute setting; 3) no
adiation dose; and 4) higher spatial resolution.
ery occlusion. The epicardium is traced in green; the endocar-
at risk (delineated in yellow). (Middle) DE-CMR showing myo-
inclusion of infarcted region showing the amount of salvagedR
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575lthough quantification of myocardium at risk by
2-STIR at day 1 and week 1 did not show any
ignificant difference, image quality was in favor to
2-STIR imaging at week 1.
yocardial salvage. The clinical usefulness of the
resent study is mainly that the size of myocardium
t risk and MI, and therefore myocardial salvage,
an be assessed at the same image session within 1
eek after acute coronary occlusion, without inter-
ering with patient care in the acute setting. In acute
nfarcts, the necrotic region is surrounded by a
egion of reversible injury, characterized by edema,
nd consists of myocardial tissue that has not
ndergone irreversible injury. This region is re-
erred to as the salvageable myocardium at risk, and
he region of irreversible injury, if left untreated,
ill expand in the first hours after acute MI in
ccordance with the wavefront phenomena de-
cribed by Reimer et al. (27). To assess reperfusion
herapy, it is necessary to determine how much
yocardium is salvaged by measuring final infarct
ize in relation to the initial myocardium at risk.
E-CMR has the ability to quantify final infarct
ize (6,7), and, as shown in this study, T2-STIR
ccurately quantifies myocardium at risk. Therefore,
MR has the ability to calculate salvaged myocar-
ium within the same imaging acquisition session
21). This can be used to evaluate new drugs and
herapeutic procedures aimed at reducing infarct
ize without interfering with patient care in the
cute setting. Indeed, Ibanez et al. (28) recently
howed that metoprolol administered before revas-
ularization increased myocardial salvage in a pig
odel where myocardium at risk and final infarct
ize were assessed with T2-STIR and DE-CMR.
he results of the current study in patients with
rimary PCI showed that 75% (range 41% to 100%)
f the initial myocardium, on average, was salvaged.
ence, this line of research can be applied in
atient populations providing a salvageable index
or each patient undergoing primary PCI after acute
I and would potentially increase the knowledge
n infarct-related tissue injury.
tudy limitations. The present study was performed
n a limited number of patients, all presenting with
rst-time STEMI and undergoing successful reper-
usion. Thus, how this would translate to other
opulations, for example unsuccessful revasculariza-
ion, patients treated with thrombolytic therapy, or
atients with previous MIs, is not known (15).
nly 2 women were included in this study, and
ore data on female subjects are, therefore, needed.
owever, T2-STIR images from the 2 female aubjects showed similar enhancement as the 14
ale patients, and there is no a priori reason to
xpect a gender difference in edema formation after
cute MI. Quantification of myocardium at risk by
PECT has previously been performed using ses-
amibi tracers. In the present study, tetrofosmin was
sed; however, sestamibi and tetrofosmin are used
nterchangeably in patient studies (29). Image qual-
ty can be a limitation in assessing myocardium at
isk by T2-STIR, and the image quality of the
resent study did not allow for automated segmen-
ation. New sequences, however, are continuously
eveloped to overcome this problem (30,31). Im-
ges were acquired using a body array coil with the
iemens scanner and a cardiac surface coil with the
hilips scanner. It has been suggested that a body
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urface coil has an inherent signal intensity gradient
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maging techniques uses differences in coil sensitiv-
ty and, therefore, compensates inhomogenous re-
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arallel imaging factor (SENSE factor) of 1 to
inimize this effect.
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